Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab

M Willis, O Pearson, Zsolt Illés, C Nielsen, Tobias Sejbæk Mathiesen, Martin Duddy, K Petheram, C van Munster, J Killestein, B Uitdehaag, C Malmestrom, E Tallantyre, N Robertson

Research output: Contribution to conference without publisher/journalPosterResearch

Original languageEnglish
Publication date14. Sept 2016
Publication statusPublished - 14. Sept 2016
Event32nd ECTRIMS: Congress of the European Committee for Treatment and Research in Multiple Sclerosis - ExCeL London, London, United Kingdom
Duration: 14. Sept 201617. Sept 2016

Conference

Conference32nd ECTRIMS
LocationExCeL London
Country/TerritoryUnited Kingdom
CityLondon
Period14/09/201617/09/2016

Cite this